Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,086 | 81,849 | 0 | 0 | N/A |
| TOTAL | $153,704 | $83,458 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,251 | 4,442 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,075 | 2,804 | 0 | 0 | 0 |
| TOTAL | $6,326 | $7,246 | $N/A | $N/A | $N/A |
| Total Assets | $160,030 | $90,704 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,401 | 1,736 | 0 | 0 | 0 |
| Accrued Expenses | 4,339 | 3,488 | 0 | 0 | N/A |
| TOTAL | $7,355 | $5,831 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 360 | 215,888 | 0 | 0 | 0 |
| TOTAL | $360 | $215,888 | $N/A | $N/A | $N/A |
| Total Liabilities | $7,715 | $221,719 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,217 | 29,211 | N/A | N/A | N/A |
| Retained earnings | -152,137 | -140,503 | 0 | 0 | N/A |
| TOTAL | $152,315 | $-131,015 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $160,030 | $90,704 | $0 | $0 | $0 |